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Abstract 
Background: Malaria and HIV infections are both highly prevalent in sub-Saharan Africa, with HIV-infected patients 
being at higher risk of acquiring malaria. HIV-1 infection is known to impair the immune response and may increase 
the incidence of clinical malaria. However, a positive association between HIV-1 and malaria parasitaemia is still 
evolving. Equally, the effect of malaria on HIV-1 disease stage has not been well established, but when fever and 
parasitemia are high, malaria may be associated with transient increases in HIV-1 viral load, and progression of HIV-1 
asymptomatic disease phase to AIDS.
Objective: To determine the effects of HIV-1 infection on malaria parasitaemia among consented residents of Milo 
sub-location, Bungoma County in western Kenya.
Study design: Census study evaluating malaria parasitaemia in asymptomatic individuals with unknown HIV-1 
status.
Methods: After ethical approvals from both Moi University and MTRH research ethics committees, data of 3,258 par-
ticipants were retrieved from both Webuye health demographic surveillance system (WHDSS), and Academic Model 
Providing Access to Healthcare (AMPATH) in the year 2010. The current study was identifying only un-diagnosed HIV-1 
individuals at the time the primary data was collected. The data was then analysed for significant statistical association 
for malaria parasitemia and HIV-1 infection, using SPSS version 19. Demographic characteristics such as age and sex 
were summarized as means and percentages, while relationship between malaria parasitaemia and HIV-1 (serostatus) 
was analyzed using Chi square.
Results: Age distribution for the 3,258 individuals ranged between 2 and 94 years, with a mean age of 26 years old. 
Females constituted 54.3%, while males were 45.8%. In terms of age distribution, 2–4 years old formed 15.1% of the 
study population, 5–9 years old were 8.8%, 10–14 years old were 8.6% while 15 years old and above were 67.5%. Of 
the 3,258 individuals whose data was eligible for analysis, 1.4% was newly diagnosed HIV-1 positive. Our findings 
showed a higher prevalence of malaria in children aged 2–10 years (73.4%), against the one reported in children in 
lake Victoria endemic region by the Kenya malaria indicator survey in the year 2010 (38.1%). There was no significant 
associations between the prevalence of asymptomatic malaria and HIV-1 status (p = 0.327). However, HIV-1/malaria 
co-infected individuals showed elevated mean malaria parasite density, compared to HIV-1 negative individuals, 
p = 0.002.
Conclusion: HIV-1 status was not found to have effect on malaria infection, but the mean malaria parsite density was 
significantly higher in HIV-1 positive than the HIV-1 negative population.
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Background
The clinical burden of malaria and HIV/AIDS in sub-
Saharan Africa is well-described, but the dynamics of 
the interaction between the two diseases remains poorly 
understood. Malaria and HIV infections are both highly 
prevalent in sub-Saharan Africa, with HIV-infected 
patients being at higher risk of acquiring malaria [1]. 
Conversely, HIV-1 infection is known to impair the 
immune response, and increase the incidence of clinical 
malaria. However, a positive association between HIV-1 
and malaria parasitaemia has not been fully explored. 
Equally, the effect of malaria on HIV-1 disease stage 
has not been well established, but when fever and para-
sitemia are high, malaria may be associated with tran-
sient increase in HIV-1 viral load and progression of 
HIV-1 asymptomatic disease phase to AIDS [2, 3].
In Kenya, malaria remains one of the greatest public 
health problems, contributing to 30% of all the outpa-
tient consultations, and 19% of hospital admissions [4]. 
In addition, HIV-1 prevalence among 15–49 years old as 
per the Kenya Demographic and Health Survey of 2008–
2009 was 6.3%, with reported 44 new infections every 
day [4, 5]. By the year 2002 HIV-1 and malaria were the 
leading causes of mortality in the African region [6]. In 
addition, HIV-1 and malaria have currently been docu-
mented to be very common in sub-Saharan Africa, with 
hypothesized potential of interactions. Malaria has been 
implicated in the increase of HIV-1 viral load and, as a 
result, a decrease in CD4+ T cells, high rates of HIV-1 
transmission and rapid disease progression to AIDS. On 
the other hand, immunosuppressive effects due to HIV-1 
infection has been associated with increased episodes of 
clinical malaria, and increased fatality rates in endemic 
regions [7–9].
A number of studies have shown some correlations in 
interactions between HIV-1 and malaria infections on 
patients’ outcome [10–12]. However, there is still emerg-
ing evidence of malaria and HIV-1 co-infection dynam-
ics and relationships. Combined anti-retroviral (cARV) 
and anti-malarial prophylactic drug interactions are also 
known to pose a serious threat to their efficacy, and could 
lead to synergistic toxicities, given that majority of cART 
and anti-malarial drugs are metabolized by the CYP450 
system, creating a chance of drug–drug interaction upon 
co-administration [13].
These multiple interactions have serious implications 
on service delivery and are of public health concern in the 
management of HIV-1 and malaria epidemics. Therefore, 
in HIV-1 infected individuals, a malaria case definition 
based on fever alone, which is a regular management tool 
for clinically diagnosing malaria in resource limited areas 
may be misleading. Furthermore, in advanced HIV-1 
disease, anaemia is a common hematological presenta-
tion, in which malaria is thought to have a contributory 
role. HIV-1 co-infection has been implicated in increased 
risk of malaria associated anemia and poor recovery, than 
in HIV-1 negative patients [11].
The current study, therefore, sought to investigate the 
effects of untreated HIV-1 infection on malaria parasi-
taemia among residents of Milo sub-location, Webuye 
district in Bungoma County in western Kenya. Western 
Kenya has an HIV-1 prevalence of 6.6% among men and 
women aged between 15 and 49 years, a 0.3% higher than 
that of national mean for Kenya [5]. It is also a region 
with malaria endemicity, making it a good model for 
the study of association between HIV-1 infection and its 
affects on malaria parasitaemia.
Methods
Study population
Milo sub-location, in which the project was conducted, 
is one of the six sub-locations within Webuye Health 
Demographic Surveillance System (WHDSS) in Bun-
goma County Western Kenya. It is a transitional zone 
between areas of stable and unstable malaria transmis-
sions, with a high prevalence of HIV-1. This provided a 
potential ground to investigate the interactions of these 
two infectious agents.
After ethical approvals from both Moi University and 
MTRH research ethics committees, data from 3,258 con-
sented participants as well as children whose parents 
or guardians gave assent, and who were involved in the 
malaria and HIV-1 survey were retrieved. These were 
adults and children above 2 years old, and had lived for 
more than 4 months within Milo sub-location. From the 
retrieved data, the current study comprised of individuals 
with asymptomatic malaria, and were not aware of their 
HIV-1 status.
After authorization to use data was granted by both 
AMPATH and WHDSS, demographic details and infor-
mation on malaria were retrieved from Webuye Health 
Demographic Surveillance System (WHDSS) data base, 
while data on HIV-1 was accessed from the records of 
Home based counseling and testing for HIV-1, that was 
conducted by AMPATH in the year 2010. Participants’ 
confidentiality was maintained by ensuring that names 
or any other special identifiable characteristics of an indi-
vidual participant did not appear in the study.
Malaria parasitaemia
For the purpose of WHDSS data base, a finger-prick 
blood drop was taken from individual participants to 
make a thick smear and then stained with 10% Giemsa. 
The slides were examined by two independent trained 
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technologists, and results recorded as positive or nega-
tive for malaria. Where discordance arose, an independ-
ent qualified assessor re-examined the discordant blood 
slide(s) readings, and the findings were then adopted. 
Malaria positive smears were used to determine the 
malaria parasite density (MPD) for each participant, by 
counting parasites in each thick blood smears. In every 
total 200 white blood cells (WBC) assessed, malaria par-
asites were then calculated for each positive smear, and 
reported per micro-litre (µl) of blood using the following 
standard formula as per the WHO [12].
HIV sero‑status
For the purpose of AMPATH database, data on HIV-1 
sero-status was collected concurrently with WHDSS 
malaria parasitaemia surveillance. Informed consent 
was obtained for HIV-1 testing for every individual in 
the community in which house to house visits were 
conducted, followed with a finger prick to obtain drops 
of blood for HIV testing. For the minors, assent was 
obtained from the parents or their guardians. Three 
standard rapid tests (Determine® HIV-1/2; Inverness 
Medical Japan, SDBioline® HIV 1/2 3.0; Standard Diag-
nostics Inc. and Unigold® Trinity biotech PLC, Ireland) 
were used to determine the HIV status according to 
manufacturers’ specifications. First, Determine® HIV1/2 
was used and results recorded. For negative individu-
als, no further tests were done. For positive reactions, 
the results were verified using SD Bioline® HIV1/2, in 
which case a positive test confirmed HIV sero-positivity. 
If the two tests were discordant, a third rapid test was 
done using Unigold® to reconcile the results. In addi-
tion, fourth generation ELISA (Vironostika, France) was 
done for discordant couples, and every 20th specimen 
for quality assurance and quality control. Results were 
communicated to the participants and counseling done 
accordingly. Those who tested positive were thereafter 
enrolled to the nearby AMPATH clinic for further coun-
seling, evaluation and care.
Data analysis
Data was imported to SPSS from excel spread sheet, and 
analyzed using SPSS version 19 (SPSS, Chicago IL, USA). 
Demographic characteristics such as age and sex were 
summarized into means and percentages. Association 
between HIV-1 and malaria prevalence was subjected to 
Chi square analysis for significant statistical correlation, 
while adjusting for age. Values of p < 0.05 were consid-
ered statistically significant.
Parasites per µl of blood
=





Data for 3,258 consented participants was eligible for 
analysis, which constituted 97% of the total population 
in the records. Females constituted 54.3%, while males 
were 45.8%. In terms of age distribution, 2–4  years old 
formed 15.1%, 5–9 years old were 8.8%, 10–14 years old 
were 8.6% while 15 years old and above were 67.5% of the 
participants. The prevalence of newly diagnosed HIV-1 
positive individuals was 1.4% (46 out of the 3,258 partici-
pants), with the highest HIV-1 positive individuals being 
between 15 and 49 years. Out of the HIV-1 positive cat-
egory, females were 71.7%, while males were 28.3%.
Prevalence of malaria parasitemia (Plasmodium falciparum) 
and HIV‑1 co‑infection
From the consented participants, 64.3% tested positive, 
while 35.7% were negative for malaria parasite. For the 
HIV-1 negative cluster 35.6% were positive, while 64.4% 
were negative for malaria parasite. In the HIV-1 positive 
cluster, 58.7% were positive, while 41.3% were negative 
for malaria parasite. However, no significant statistical 
relationship between malaria parasitemia and HIV-1 co-
infection was found (P = 0.327) (Additional file 1: Table 
S1).
Malaria parasite density
Mean malaria parasite density was compared between 
the HIV-1 positive and HIV-1 negative individuals, and 
was found to be 2,008.9/µl, SD 7,602.3 and 1,043.7/µl, SD 
3,029.5 in HIV-1 positive and HIV-1 negative categories, 
respectively (P  =  0.002). The medians for the parasite 
densities were 440 and 480 for HIV-1 positive and HIV-1 
negative categories, respectively (Additional file 1: Table 
S1).
Discussion
Both malaria and HIV-1 infections are still highly preva-
lent in sub-Saharan Africa, with HIV-1 infected patients 
being at higher risk of acquiring malaria [13]. In addition, 
HIV-1 infection has been associated with an increase in 
malaria parasite density, delayed parasite clearance, a 
higher incidence of clinical and severe malaria, as well as 
increased death rate. Other studies have also suggested 
that there is an increase in plasma HIV-1 RNA levels 
observed during an episode of clinical malaria, which 
involves a complex interplay of several factors. However, 
despite the growing body of evidence on the pathophysi-
ological and epidemiological interactions between HIV-1 
and malaria in sub-Saharan Africa, the dynamics of the 
interaction between the two diseases remain poorly 
understood [14–17].
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The present study showed that, in a region consid-
ered to be hyperendemic for malaria, even though it is 
a transitional zone between hyperendemic and meso 
endemic malaria zones, the overall malaria preva-
lence was 64.3% [18, 19]. For the age group 2–10 years, 
malaria prevalence was 73.4%, which was higher than 
38.1% reported in children in lake Victoria endemic 
region by the Kenya malaria indicator survey in the 
year 2010. This disparity could be attributed to a wider 
region of coverage by the KMIS in 2010, resulting into 
a lower mean, as compared to the result from our 
study. However, data for our study was obtained from 
a survey study conducted during malaria peak season 
of October to November 2010. Similarly, the Kenya 
malaria indicator survey data resulted from a different 
peak malaria season of June–August 2010 [18]. A closer 
comparison to our findings was from a study of popula-
tion based survey of Plasmodium falciparum in west-
ern Kenya highlands carried out during the months of 
July–December in the year 2002, which found a preva-
lence of malaria among children aged between 2 and 
4 years to be 62.8% [19].
Although the percentage positive for malaria parasi-
taemia in the HIV-1 positive category in our study was 
higher compared to the HIV-1 negative cluster, infection 
with the virus did not seem to have any significant effect 
on the prevalence of malaria in the assessed individuals. 
[20–22]. However, the mean malaria parasite density in 
HIV-1 infection was found to have impact on malaria 
parasitaemia, compared with HIV-1 negative group, a 
factor likely associated with immunosuppressive effects 
of HIV-1 [22, 23].
Until now, there is no consensus regarding the effect of 
HIV-1 on malaria. Some earlier studies found no effect of 
HIV-1 on the susceptibility and severity of malaria, but 
recent investigations suggest that HIV-1-infected indi-
viduals with lower CD4 cell counts may be more likely 
to present with symptomatic malaria, and malaria may 
enhance HIV-1 vertical transmission [24]. The above 
phenomena has, however, been contradicted by some 
studies showing that HIV-1 replication is increased 10 to 
100-fold in peripheral blood mononuclear cells exposed 
to soluble malaria antigens and [25].
In addition, it has been shown that in regions where 
HIV and malaria parasites are both highly endemic, 
acute bouts of malaria drive higher plasma HIV RNA lev-
els [26]. Decline in the CD4+ T cell count has also been 
reported to be accelerated by clinically apparent bouts of 
Plasmodium falciparum malaria [27]. Although clinical 
data have not yet been demonstrated, it is quite possible 
that subclinical parasitemia as it was for our study may 
also contribute to this phenomenon of detection of HIV 
in asymptomatic malaria positive individuals.
There are, though, some limitations to this study. First, 
this was a surveillance study that could not analyze in 
details the complex interplay of the effects of HIV on 
malaria by evaluating levels of CD4+/CD8+ T cells ratio 
and HIV disease stage. In addition, the study assessed 
asymptomatic malaria individuals who were not on any 
medication for either malaria or HIV management. This 
is in light of the fact that several studies have shown that 
combination antiretroviral therapy has great potential to 
reduce HIV-related malaria. Cotrimoxazole prophylaxis, 
recommended for adults and children living with HIV in 
Africa, for instance, has been reported to be effective in 
reducing clinical malaria, independent of baseline CD4 
[28, 29].
Conclusion
Our findings indicate that HIV infection did not show 
any influence on malaria parasitemia. However, the mean 
malaria parasite density was significantly higher in HIV 
positive group than the HIV negative population, a chal-
lenging finding that should necessitate further studies on 
the link between HIV infection and malaria parasite den-
sity levels.
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